DANCR and COVID-19: Furthermore, aged patients under prolonged anti-cholinergic medications are at increased risk of cognitive decline (135), and our findings of the apparent cholinergic-DANCR-NEAT1 links raise the question if such patients would also display excessive susceptibility to failed ncRNA response and hence harsh cognitive consequences of COVID-19.